ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018, at 11:30 a.m. Eastern Time in New York City.
March 20, 2018
· 2 min read